Novome Biotechnologies Initiates Phase 1/2a Study to Evaluate Therapeutically Engineered Bacteria for the Treatment of Enteric Hyperoxaluria

by NASDAQ Market News June 30, 2021

NASDAQ Market News
Click here to email author

Biomedical Sensors Market to Outstrip $15,338.57 Million by 2027 Growing Sturdy at 7.4% CAGR – COVID-19 Impact and Global Analysis by TheInsightPartners.com

Ethics Approval for Cynata’s Clinical Trial in Diabetic Foot Ulcers

Ads